207 related articles for article (PubMed ID: 15690641)
1. Megakaryoblastic disorders in children.
Lorsbach RB
Am J Clin Pathol; 2004 Dec; 122 Suppl():S33-46. PubMed ID: 15690641
[TBL] [Abstract][Full Text] [Related]
2. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
4. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
[TBL] [Abstract][Full Text] [Related]
5. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
[TBL] [Abstract][Full Text] [Related]
6. Transient myeloproliferative disorder.
Moiz B; Shafiq M
Blood; 2012 Dec; 120(24):4672. PubMed ID: 23350067
[No Abstract] [Full Text] [Related]
7. Acute megakaryoblastic leukemia following transient myeloproliferative disorder in a patient without Down syndrome.
Brissette MD; Duval-Arnould BJ; Gordon BG; Cotelingam JD
Am J Hematol; 1994 Dec; 47(4):316-9. PubMed ID: 7977305
[TBL] [Abstract][Full Text] [Related]
8. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
9. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
10. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
Azad VF; Mehrvar A; Mehrvar N
J Cancer Res Ther; 2018 Sep; 14(Supplement):S800-S802. PubMed ID: 30249908
[TBL] [Abstract][Full Text] [Related]
13. Acute megakaryoblastic leukemia with der(7)t(5;7)(q11;p11 approximately p12) associated with Down syndrome: a fourth case report.
Roche-Lestienne C; Dastugue N; Richebourg S; Roquefeuil B; Dalle JH; Laï JL; Andrieux J
Cancer Genet Cytogenet; 2006 Sep; 169(2):184-6. PubMed ID: 16938582
[No Abstract] [Full Text] [Related]
14. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
15. Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
Inaba H; Londero M; Maurer SH; Onciu M; Ge Y; Taub JW; Rubnitz JE; Raimondi SC
J Clin Oncol; 2011 Mar; 29(9):e230-3. PubMed ID: 21205752
[No Abstract] [Full Text] [Related]
16. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.
Gamis AS; Alonzo TA; Gerbing RB; Hilden JM; Sorrell AD; Sharma M; Loew TW; Arceci RJ; Barnard D; Doyle J; Massey G; Perentesis J; Ravindranath Y; Taub J; Smith FO
Blood; 2011 Dec; 118(26):6752-9; quiz 6996. PubMed ID: 21849481
[TBL] [Abstract][Full Text] [Related]
17. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukemia accompanying Down syndrome.
Shimada A; Xu G; Toki T; Kimura H; Hayashi Y; Ito E
Blood; 2004 Jan; 103(1):366. PubMed ID: 14684662
[No Abstract] [Full Text] [Related]
18. JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults.
Kiyoi H; Yamaji S; Kojima S; Naoe T
Leukemia; 2007 Mar; 21(3):574-6. PubMed ID: 17252020
[No Abstract] [Full Text] [Related]
19. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
20. A t(1;22)(p13;q13) in four children with acute megakaryoblastic leukemia (M7), two with Down syndrome.
Trejo RM; Aguilera RP; Nieto S; Kofman S
Cancer Genet Cytogenet; 2000 Jul; 120(2):160-2. PubMed ID: 10942809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]